This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goddard, A. F.
Right arrow Articles by Spiller, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goddard, A. F.
Right arrow Articles by Spiller, R. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Jun 1997, 1246-1249, Vol 41, No. 6
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

In vitro assessment of gastric mucosal transfer of anti-Helicobacter therapeutic agents

AF Goddard and RC Spiller
Division of Gastroenterology, University Hospital, Nottingham, United Kingdom. muzafg@mmm1.nottingham.ac.uk

A novel animal model for studying antibiotic transfer across gastric mucosa was developed by using adult rats. Gastric corpus mucosa was mounted in an Ussing chamber system and bathed in oxygenated Krebs solution. Metronidazole flux from serosa to mucosa (J(S-->M)) was measured over 60 min under basal conditions and compared with mucosa-to- serosa flux (J(M-->S)). The effects of varying the chamber cross- sectional diameter and of stimulation by histamine and carbachol were assessed. Metronidazole J(M-->S) was measured with the mucosal pH at 2.2, 2.7, 3.2, and 7.4. Amoxicillin J(S-->M) under basal conditions was also measured and compared with metronidazole J(S-->M). Metronidazole J(S-->M) was proportional to serosal concentration (P < 0.001) under basal conditions, being 3.98 nmol x h(-1) x cm(-2) with a serosal concentration of 0.2 mmol/liter. Amoxicillin J(S-->M) was significantly lower under similar conditions at 0.50 nmol x h(-1) x cm(-2) (P < 0.01). Metronidazole J(S-->M) was not significantly different from J(M-- >S), between chambers of different sizes, or following stimulation. When the mucosal pH was changed, J(M-->S) was proportional to the un- ionized concentration on the mucosal side (P < 0.001). Therefore, this model shows properties analogous to those of human gastric mucosa in vivo, with partitioning of metronidazole on the mucosal side according to pH, diffusion of metronidazole across the mucosa in both directions, and selectivity for different antibiotics, and it will be useful for the study of other therapeutic agents in the treatment of Helicobacter pylori.


This article has been cited by other articles:

  • Pellegrini, M, Urso, R, Giorgi, G, Cerretani, D, Spiller, R C, Sherwood, P (2004). Influence of antisecretory drugs on Helicobacter pylori eradication rates * Authors' reply. Gut 53: 1720-1720 [Full Text]  
  • Matysiak-Budnik, T., Heyman, M., Candalh, C., Lethuaire, D., Megraud, F. (2002). In vitro transfer of clarithromycin and amoxicillin across the epithelial barrier: effect of Helicobacter pylori. J Antimicrob Chemother 50: 865-872 [Abstract] [Full Text]  
  • Sherwood, P V, Wibawa, J I D, Atherton, J C, Jordan, N, Jenkins, D, Barrett, D A, Shaw, P N, Spiller, R C (2002). Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats. Gut 51: 490-495 [Abstract] [Full Text]  
  • Lozniewski, A., Duprez, A., Renault, C., Muhale, F., Conroy, M.-C., Weber, M., Le Faou, A., Jehl, F. (1999). Gastric Penetration of Amoxicillin in a Human Helicobacter pylori-Infected Xenograft Model. Antimicrob. Agents Chemother. 43: 1909-1913 [Abstract] [Full Text]